Journal of Clinical Medicine published recent research by Goudman and colleagues on central sensitisation in an online survey among 567 Belgian Long-COVID patients. Central sensitisation is an amplification of neural signalling within the central nervous system that elicits pain hypersensitivity. The study shows the presence of central sensitisation symptoms in over 70% of the Long-COVID patients providing much-needed insights into the etiology and treatment opportunities. 

The article is available via https://www.mdpi.com/2077-0383/10/23/5594